| Effervescent pharmaceutical formulation for treating and preventing diseases such as osteoporosis, comprises alendronate sodium or its salt, acid component, base component, and lubricant, where formulation is prepared by fluidized bed granulation, and formulation has specified moisture content | |
| 2024-10-22 | |
| 专利权人 | MEDLEY PHARM LTD (MEDL-Non-standard) |
| 申请日期 | 2024-10-22 |
| 专利号 | IN202421080075-A |
| 成果简介 | NOVELTY - An effervescent pharmaceutical formulation comprises alendronate sodium or its salt, an acid component, a base component, and a lubricant, where the formulation is prepared by fluidized bed granulation, and the formulation has a moisture content of 0.1-3 wt.% of the total blend. USE - Effervescent pharmaceutical formulation for treating and preventing diseases such as osteoporosis, osteoarthritis, Paget's disease, osteohalisteresis, osteomalacia, bone loss from multiple myeloma and other cancers, bone loss from steroid use, disuse, or rheumatoid related conditions, and age-related loss of bone mass. No biological data given. ADVANTAGE - The effervescent pharmaceutical formulation ensures improved patient compliance and therapeutic efficacy, ease of administration, improved patient adherence, rapid disintegration time of less than 60 seconds, high mechanical strength, improved palatability, solubility, and stability, and is easy to ingest, and can be prepared without adding binder, in rapid manner. |
| IPC 分类号 | A61K-031/13 ; A61K-031/66 ; A61K-031/662 ; A61K-047/02 ; A61K-047/12 ; A61K-009/46 |
| 国家 | 印度 |
| 专业领域 | 医药卫生 |
| 语种 | 英语 |
| 成果类型 | 专利 |
| 文献类型 | 科技成果 |
| 条目标识符 | http://119.78.100.226:8889/handle/3KE4DYBR/14806 |
| 专题 | 中国科学院新疆生态与地理研究所 |
| 作者单位 | MEDLEY PHARM LTD (MEDL-Non-standard) |
| 推荐引用方式 GB/T 7714 | PAGAR S,SHAIKH P,SAHU S,et al. Effervescent pharmaceutical formulation for treating and preventing diseases such as osteoporosis, comprises alendronate sodium or its salt, acid component, base component, and lubricant, where formulation is prepared by fluidized bed granulation, and formulation has specified moisture content. IN202421080075-A[P]. 2024. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论